Tag
GPT Healthcare Limited
5 articles
GPT Healthcare Limited demonstrated solid revenue growth in fiscal year 2026, with a 15.14% increase to ₹478.5 crore, driven by strong performance in its established hospitals and bolstered by over 800 robotic surgeries. However, profitability was pressured by losses from the newly opened Raipur hospital, which negatively impacted the overall EBITDA margin. Despite this, the company remains focused on expansion, recently announcing a new 150-bed facility in Jamshedpur with a ₹75 crore investment, signaling continued confidence in the healthcare sector's growth potential and a commitment to delivering shareholder value through dividends.
GPT Healthcare Q4 Revenue Up 24.3% YoY
GPT Healthcare reported Q4 FY26 revenue of ₹128.0 crore, a 24.3% YoY increase, with PAT at ₹14.7 crore.
Full-year FY26 PAT declined 15.43% to ₹42.2 crore despite a 15.14% revenue growth to ₹478.5 cror
GPT Healthcare FY26 Revenue Rises 15% to ₹478.5 Cr
GPT Healthcare reported FY26 revenue of ₹478.5 Cr, up 15.14% YoY, though PAT declined 15.43% to ₹42.2 Cr due to new Raipur hospital losses.
The new 158-bed Raipur hospital reported negative EBITDA of
GPT Healthcare Q4 FY26 Net Profit ₹14.57 Crore
Board approved audited Q4 and FY26 financial results with a net profit of ₹14.57 crore and ₹42.72 crore respectively.
Recommended a final dividend of ₹1.50 per share for FY26, subject to shareholder a
GPT Healthcare Schedules Q4 FY26 Earnings Call
GPT Healthcare Limited will host an earnings call on May 19, 2026, to discuss audited Q4 and FY26 financial results.
The call will feature key management including Group CFO Atul Tantia, Executive Dir
GPT Healthcare Board Meeting on May 18, 2026
• GPT Healthcare intimated NSE and BSE about its upcoming Board meeting on May 18, 2026.
• The Board will consider audited financial results for Q4 and FY ended March 31, 2026.
• The Board will also c